Global Nanomedicine Market 2012-2016

1

Introduction Aarkstore Enterprise
Our comprehensive and wide range of databank in
the field of Market Research Report provides
exclusive, pioneering and innovative service to
our report buyers. Our high-quality databank
comprises of company profiles, strategy review,
company report, industry reports, company
financials, SWOT analysis, and industry research.
Aarkstore.com is in the forefront as it is
enriched with comprehensive informative and
interactive search features. One can browse to
have ample access of beyond 2.5 lakh business
industry reports.
2
Global Nanomedicine Market 2012-2016 at
Aarkstore.com http//www.aarkstore.com/reports/Gl
obal-Nanomedicine-Market-2012-2016-296000.html

Report
3
Published Date 19 July 2013Pages  67PDF -
  2500 You can also request for sample
page of above mention reports on
sample_at_aarkstore.com
4
TechNavios analysts forecast the Global
Nanomedicine market to grow at a CAGR of 12.57
percent over the period 2012-2016. One of the key
factors contributing to this market growth is the
emergence of nanorobotics. The Global
Nanomedicine market has also been witnessing the
increasing use of novel nanomaterials. However,
lengthy approval procedures could pose a
challenge to the growth of this
market. TechNavios report, the Global
Nanomedicine Market 2012-2016, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
market in the Americas, and the EMEA and APAC
regions it also covers the Global Nanomedicine
market landscape and its growth prospects in the
coming years. The report also includes a
discussion of the key vendors operating in this
market.The key vendors dominating this space
include Abbott Laboratories, AstraZeneca plc,
Bristol-Myers Squibb Co., Celgene Corp.,
GlaxoSmithKline plc, and Pfizer Inc.The other
vendors mentioned in this report are Ablynx NV,
Acusphere Inc., Aphios Corp., Arrowhead Research
Corp., BioForce, Nanosciences Holdings Inc.,
Bio-Gate AG, Biophan Technologies Inc., BioSante
Pharmaceuticals Inc., CombiMatrix Corp., Enzon
Pharmaceuticals Inc., GE Healthcare Ltd., Gilead
Sciences Inc., IDEX Corp., IGI Laboratories Inc.,
Kereos Inc., Kimberly-Clark Corp., MIV
Therapeutics Inc., Nanobiotix S.A., NanoCarrier
Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed
Pharmaceuticals Inc., Nanotherapeutics Inc.,
NanoViricides Inc., Paladin Labs Inc., pSivida
Corp., Qiagen N.V., Roche Holding AG, Skyepharma
PLC, Smith Nephew plc, Starpharma Holdings
Ltd., Stryker Corp., and Tecan Group Ltd.Key
questions answered in this reportWhat will the
market size be in 2016 and what will be the
growth rate?What are key market trends?What is
driving this market?What are the challenges to
market growth?Who are the key vendors in this
market space?What are the market opportunities
and threats faced by key vendors?What are the
strengths and weaknesses of each of these key
vendors?You can request one free hour of our
analysts time when you purchase this market
report. Details provided within the report.